Kindeva Drug Delivery’s Woodbury, MN facility, which was launched earlier this year, has been inspected and successfully classified by the FDA. The new business unit supports both integrated and stand-alone analytical services for the pharmaceutical, biopharmaceutical, and medical device sectors. Kindeva’s analytical services site in Woodbury is now FDA registered and classified as Voluntary Action Indicated (VAI) with regards to cGMP. A Prior Approval Supplement (PAS) was submitted February...